Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PGNY · against 390 other Healthcare companies of similar size
Ranked #217 of 391 · scores higher than 45% of peers · safety percentile 47
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)39 peers with a safety percentile of 40–49, including PGNY · Click a bar to see the companies
A mix: stronger debt / equity, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | PGNY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 369 reported | 0.06× | 0.23× | 73% | 33% | |
| BetaLower is better · 370 reported | 1.02 | 0.58 | 26% | 33% | |
| Current ratioHigher is better · 376 reported | 2.14× | 2.78× | 41% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 3.6B USD | 99 | ||
| 5 | 1.2B USD | 99 | ||
| 213 | 21.3B HKD (≈$2.7B) | 48 | 68 | |
| 214 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 212.3B JPY (≈$1.4B) |
| 47 |
| 62 |
| 215 | 14.8B BRL (≈$2.7B) | 47 | 63 |
| 216 | 1.6B GBP (≈$2.1B) | 47 | 67 |
| 217 | 2.2B USD | 47 | 66 |
| 218 | 6.3B AUD (≈$4.1B) | 47 | 66 |
| 219 | 1.9B USD | 47 | 44 |
| 220 | 1.7B USD | 46 | 77 |
| 221 | 11.4B CNY (≈$1.6B) | 46 | 51 |